nVerses Capital’s Exelixis EXEL Stock Holding History

nVerses Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,300	Closed	-$231K	–	1121
2024 Q2	$231K	Buy	+10,300	New	+$229K	0.14%	243

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

nVerses Capital's EXEL Position: Q3 2024 in Review

nVerses Capital sold out of Exelixis (EXEL) in Q3 2024, closing a stake of 10,300 shares — an estimated $231K sold.

nVerses Capital first reported a position in EXEL in Q2 2024 and held it in 1 quarter. The position peaked at $231K in Q2 2024. 452 funds tracked by Wall St. Rank hold EXEL as of Q3 2024.

nVerses Capital reported no remaining Exelixis position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 10,300 Exelixis shares in Q3 2024, an estimated $231K.
nVerses Capital first reported a position in Exelixis in Q2 2024 and held it in 1 quarter.
nVerses Capital's Exelixis position peaked at $231K in Q2 2024.
452 funds tracked by Wall St. Rank held Exelixis as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.